Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2012 by Japanese Gynecologic Oncology Group.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
Japanese Gynecologic Oncology Group
ClinicalTrials.gov Identifier:
NCT00226915
First received: September 23, 2005
Last updated: April 2, 2012
Last verified: April 2012